Identification of Potential Treatments for Acute Lymphoblastic Leukemia through Integrated Genomic Network Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15121562
Abstract: The advancement of high-throughput sequencing and genomic analysis revealed that acute lymphoblastic leukemia (ALL) is a genetically heterogeneous disease. The abundance of such genetic data in ALL can also be utilized to identify potential targets… read more here.
Keywords: genomic network; analysis; integrated genomic; network analysis ... See more keywords